McKinsey to pay $650 million over role in OxyContin epidemic
McKinsey agreed to pay $650 million as part of a deferred prosecution agreement, according to court documents filed Friday. As part of the agreement, McKinsey will "not do any work related to the marketing, sale, promotion or distribution of controlled substances" and will not contest the facts of the government's criminal charges.
McKinsey to Pay $650 Million in Opioid Settlement With Justice Department
McKinsey & Company has agreed to pay $650 million to settle a Justice Department investigation of its work with the opioid maker Purdue Pharma. A former senior partner has also agreed to plead guilty to obstruction of justice for destroying internal company records in connection with that work.
Consulting firm McKinsey to pay $650 million to end opioid criminal probe
The investigation stems from the company’s work advising Purdue Pharma on how to “turbocharge” sales of the blockbuster opioid OxyContin, officials said.
In Virginia court, firm agrees to pay $650 million to resolve US opioid charges
McKinsey & Company agrees to pay $650 million to settle a federal investigation regarding its work with opioids manufacturer Purdue Pharma to boost sales of OxyContin.
Consulting firm McKinsey & Company to pay $650M for helping Purdue Pharma sell OxyContin
The major consulting firm McKinsey & Company will pay $650 million to resolve criminal and civil investigations into its consulting for Purdue Pharma, the company that helped to fuel America’s opioid epidemic through its OxyContin prescription drug.
Consulting firm McKinsey to pay $650 million to resolve US opioid charges
McKinsey & Co has agreed to pay $650 million to resolve charges over advice it provided Purdue Pharma on how to "turbocharge" sales of its addictive painkiller OxyContin, the U.S. Department of Justice said on Friday.
McKinsey to pay $650 million for conduct related to Purdue Pharma, opioid crisis
The global consulting giant McKinsey & Company will pay $650 million to resolve criminal and civil probes stemming from the services it provided to Purdue Pharma.
McKinsey & Company to Pay $650M to Resolve Federal Probe Into Opioids Work
Court papers reportedly show the consulting firm will avoid prosecution in a deal with the Justice Department.
McKinsey to pay $650m to settle opioid charges
Consulting firm McKinsey has agreed to pay $650m (£515m) to settle criminal charges related to its role in the US opioid crisis. The company "knowingly and intentionally" conspired with pharmaceutical firm Purdue Pharma to "aid and abet the misbranding of prescription drugs... without valid prescriptions", according to the US Department of Justice.
Consulting firm McKinsey to pay $650 million to resolve US criminal opioid probe
McKinsey & Co has agreed to pay $650 million to resolve a U.S. Department of Justice investigation into the consulting firm's work advising opioid manufacturer OxyContin maker Purdue Pharma on how to boost sales.
McKinsey to pay $650 million after advising opioid maker on how to 'turbocharge' sales
McKinsey & Company agreed to pay $650 million to resolve criminal and civil investigations into its advice to opioids manufacturer Purdue Pharma.
IJR8h
‘Source Of Profound Regret’: Firm Pays Half Billion Settlement To Avoid Criminal Prosecution For Fueling Opioid Crisis
A consulting giant that helped fuel the United States’ deadly opioid epidemic agreed to pay a massive settlement to avoid ...
Courthouse News Service1d
In prosecution first, consultants on hook for $650 million for role in opioid epidemic
The agreement marks the first time a management consulting firm has been held criminally responsible for advice resulting in ...